Moleculin Biotech Inc (MBRX)
4.46
-0.17
(-3.61%)
USD |
NASDAQ |
Apr 15, 16:00
4.30
-0.16
(-3.59%)
After-Hours: 20:00
Moleculin Biotech Cash from Investing (Quarterly): -0.081M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.081M |
| September 30, 2023 | -0.028M |
| June 30, 2023 | -0.015M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.061M |
| March 31, 2022 | -0.006M |
| December 31, 2021 | -0.019M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.014M |
| September 30, 2020 | -0.34M |
| June 30, 2020 | -0.018M |
| March 31, 2020 | -0.002M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.009M |
| September 30, 2019 | -0.008M |
| June 30, 2019 | -0.019M |
| March 31, 2019 | -0.015M |
| December 31, 2018 | -0.114M |
| September 30, 2018 | -0.295M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.008M |
| December 31, 2017 | -0.016M |
| September 30, 2017 | -0.008M |
| June 30, 2017 | -0.004M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.011M |
| September 30, 2016 | -0.11M |
| June 30, 2016 | 0.03M |
| March 31, 2016 | -0.03M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.34M
Minimum
Sep 2020
--
Maximum
Mar 2021
-0.0326M
Average
-0.009M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Merck & Co Inc | 53.00M |
| Lixte Biotechnology Holdings Inc | -- |
| Moderna Inc | -538.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.407M |
| Cash from Financing (Quarterly) | 4.465M |
| Free Cash Flow | -24.22M |
| Free Cash Flow Per Share (Quarterly) | -2.773 |
| Free Cash Flow Yield | -276.3% |